Bank of New York Mellon Corp Trims Holdings in Qiagen N.V. (NYSE:QGEN)

Bank of New York Mellon Corp lessened its stake in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 4.5% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 882,919 shares of the company's stock after selling 41,846 shares during the quarter. Bank of New York Mellon Corp owned about 0.40% of Qiagen worth $35,449,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Groupama Asset Managment grew its stake in Qiagen by 8,074.0% during the fourth quarter. Groupama Asset Managment now owns 31,817,740 shares of the company's stock valued at $1,416,844,000 after acquiring an additional 32,216,761 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of Qiagen by 9.5% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 25,319,332 shares of the company's stock valued at $1,127,470,000 after purchasing an additional 2,202,040 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Qiagen by 2.5% in the fourth quarter. Wellington Management Group LLP now owns 21,782,305 shares of the company's stock worth $970,534,000 after purchasing an additional 531,362 shares during the period. Vanguard Group Inc. raised its position in shares of Qiagen by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 8,879,089 shares of the company's stock worth $397,937,000 after buying an additional 77,119 shares in the last quarter. Finally, Norges Bank bought a new stake in Qiagen during the fourth quarter valued at $181,529,000. 70.00% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have weighed in on QGEN. Barclays began coverage on Qiagen in a report on Tuesday, June 24th. They issued an "overweight" rating and a $55.00 price target on the stock. Redburn Atlantic lowered shares of Qiagen from a "buy" rating to a "neutral" rating in a research report on Friday, April 4th. Bank of America increased their price target on shares of Qiagen from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Thursday, June 26th. Wall Street Zen upgraded shares of Qiagen from a "buy" rating to a "strong-buy" rating in a research report on Thursday, May 15th. Finally, Robert W. Baird upped their target price on shares of Qiagen from $42.00 to $43.00 and gave the stock a "neutral" rating in a research report on Monday, April 21st. Seven investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, Qiagen presently has a consensus rating of "Hold" and a consensus price target of $49.40.

Qiagen Trading Down 0.3%

Qiagen stock traded down $0.17 during mid-day trading on Friday, hitting $48.08. The company's stock had a trading volume of 715,931 shares, compared to its average volume of 1,215,591. The business has a 50 day moving average price of $45.82 and a 200-day moving average price of $42.95. The company has a debt-to-equity ratio of 0.40, a current ratio of 3.37 and a quick ratio of 2.83. Qiagen N.V. has a 12 month low of $37.63 and a 12 month high of $49.30. The stock has a market cap of $10.69 billion, a price-to-earnings ratio of 120.51, a price-to-earnings-growth ratio of 2.46 and a beta of 0.68.

Qiagen (NYSE:QGEN - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.55 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.05. Qiagen had a return on equity of 14.61% and a net margin of 4.68%. The company had revenue of $483.46 million during the quarter, compared to analyst estimates of $465.66 million. During the same quarter in the previous year, the company posted $0.44 EPS. Qiagen's revenue for the quarter was up 5.2% on a year-over-year basis. As a group, analysts forecast that Qiagen N.V. will post 2.26 EPS for the current year.

Qiagen Announces Dividend

The company also recently announced a dividend, which was paid on Thursday, July 10th. Investors of record on Thursday, July 3rd were paid a $0.25 dividend. This represents a dividend yield of 0.52%. The ex-dividend date was Wednesday, July 2nd. Qiagen's payout ratio is 62.50%.

Qiagen Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.